Neurosense Therapeutics is trading at $0.50 (+6.21%) despite a lack of fresh company-specific announcements, earnings reports, or regulatory updates.
- The upward move appears consistent with small-cap volatility and a broader risk-on sentiment as U.S. equities trade higher during the August 4 session.
- Recent price action has been characterized by thin liquidity and choppy trading, including a similar jump to $0.50 during after-hours sessions on July 31.